GSK3178022 is a human IgG1 monoclonal antibody (mAb) that targets LRP6. It inhibits the expression of the WNT target genes SP5 and AXIN2 and demonstrates antitumor activity in colorectal cancer RSPO fusion models. The recommended isotype control is HumanIgG1kappa, Isotype Control.
Target:
Wnt/beta-catenin|||LPL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted